Lexicon Pharmaceuticals, Inc. (LXRX) Operating cash flow 2016–2025
Lexicon Pharmaceuticals, Inc. (LXRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$67.9MFY2025 · since FY2016: -$175.6M → -$67.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$67.9M | +62.0% |
| FY2024 | -$178.8M | -10.4% |
| FY2023 | -$161.9M | -82.2% |
| FY2022 | -$88.9M | -2.1% |
| FY2021 | -$87.0M | +39.1% |
| FY2020 | -$143.0M | -225.6% |
| FY2019 | $113.8M | +176.6% |
| FY2018 | -$148.6M | +19.8% |
| FY2017 | -$185.4M | -5.6% |
| FY2016 | -$175.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice